Scinovex
article Open AccessTop 1% cited

ISOLATION OF A TUMOR FACTOR RESPONSIBLE FOR ANGIOGENESIS

The Journal of Experimental Medicine · 1971 · Vol. 133(2) · pp. 275–288
Judah FolkmanEzio MerlerCharles M. AbernathyGretchen M. Williams

Abstract

Human and animal solid tumors elaborate a factor which is mitogenic to capillary endothelial cells. This factor has been called tumor-angiogenesis factor. The important components of TAF are RNA and protein. It is suggested that blockade of this factor (inhibition of angiogenesis) might arrest solid tumors at a tiny diameter of a few millimeters.

Angiogenesis and VEGF in CancerCancer and biochemical researchCancer Research and TreatmentsAngiogenesisBlockadeCancer researchBiologyCell biologyNeovascularizationVascular endothelial growth factor AVascular endothelial growth factorVEGF receptorsReceptor

MeSH terms

AnimalsBlood VesselsCapillariesCarcinoma 256, WalkerCarcinoma, HepatocellularHumansLiver NeoplasmsMelanomaMitosisNeoplasm TransplantationNeoplasmsWilms TumorNeuroblastomaProteinsRNA
Citations
1,661
FWCI
11.45
field-weighted impact
References
10
Percentile
99%
vs. same field & year
Citations per year
Cited by
Angiopoietins in angiogenesis
Cancer Letters · 2012 · 653 citations
Tumor Angiogenesis: Therapeutic Implications
New England Journal of Medicine · 1971 · 10,087 citations
Anti-Angiogenesis
Annals of Surgery · 1972 · 1,175 citations
Mechanisms of normal and tumor-derived angiogenesis
American Journal of Physiology-Cell Physiology · 2002 · 797 citations
Active targeting schemes for nanoparticle systems in cancer therapeutics
Advanced Drug Delivery Reviews · 2008 · 1,702 citations
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.